AUSPEX PHARMACEUTICALS INC's ticker is ASPX and the CUSIP is 05211J102. A total of 61 filers reported holding AUSPEX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2014 | $1,335,000 | – | 43,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,984,038 | $44,185,000 | 1.78% |
| Cormorant Asset Management, LP | 100,000 | $2,227,000 | 0.59% |
| WALL STREET ASSOCIATES | 225,000 | $5,011,000 | 0.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 304,076 | $6,772,000 | 0.26% |
| KNOTT DAVID M | 35,366 | $787,601,000 | 0.14% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 116,028 | $2,584,000 | 0.08% |
| Visium Asset Management, LP | 183,625 | $4,089,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 25,369 | $565,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 50,000 | $1,114,000 | 0.05% |
| MILLENNIUM MANAGEMENT LLC | 661,361 | $14,729,000 | 0.04% |